Precision Optics (POCI) Q3 2026 earnings review
Record Volume Powers a Margin Reversal, But Implied Q4 Looks Weak
Precision Optics delivered a breakout quarter, more than doubling YoY revenue to a record $8.7 million. The long-awaited transition from engineering to high-volume production is finally materializing, driven by aerospace and cystoscope programs. Crucially, manufacturing execution improved dramatically, driving gross margins from a dismal 2.8% in Q2 to 23.6% in Q3, flipping Adjusted EBITDA to a positive $0.3 million. A recent $10 million capital raise secures the balance sheet. However, despite raising full-year guidance, the implied Q4 numbers suggest a sequential deceleration in both top and bottom lines.
🐂 Bull Case
Production revenue surged 131% YoY to $7.6 million, validating the company's capability to move complex optical designs into high-volume manufacturing.
The $10 million public offering in March fundamentally de-risks the company, swelling cash reserves to $10.7M and providing a runway for capacity expansion.
🐻 Bear Case
Just two programs (Aerospace and Cystoscopy) accounted for $5.8M, or 66% of total Q3 revenue. Any order delays from these two customers would instantly derail growth.
Despite a positive Q3, FY26 guidance implies Q4 revenue will step down sequentially to ~$7.2M, dragging Adjusted EBITDA back into negative territory.
⚖️ Verdict: 🟢
Bullish. The execution in Q3 proves the business model can generate positive EBITDA at scale. While the implied sequential step-down in Q4 warrants monitoring, the fortified balance sheet and 50%+ annual growth trajectory overshadow near-term lumpiness.
Key Themes
Aerospace and Cystoscope Programs Hit Escape Velocity
Accelerating. The 131% YoY surge in production revenue was highly concentrated. A top-tier aerospace customer reached a record $3.6M (up from the engineering phase), and the single-use cystoscopy system added a record $2.2M. The company has successfully transitioned its pipeline into tangible, high-volume run rates.
Gross Margin Recovers via Manufacturing Leverage
Reversing. Gross margins snapped back aggressively to 23.6%, up from a highly concerning 2.8% in the sequential prior quarter (26Q2). Management explicitly credited new manufacturing leadership and volume leverage for the efficiency gains. This operational reset was the sole reason Adjusted EBITDA turned positive.
Implied Q4 Guidance Contradicts Growth Narrative
A close look at the math reveals a concern: YTD revenue is $22.75M. The new FY26 guidance midpoint is $30M, which implies Q4 revenue of roughly $7.25M. This represents a sequential deceleration from Q3's $8.7M. Similarly, YTD Adjusted EBITDA is $(2.44)M; the $(2.6)M guidance midpoint implies Q4 EBITDA will revert to negative $(0.16)M. The Q3 beat may have pulled forward revenue, rather than establishing a new baseline.
Extreme Margin Volatility Raises Execution Questions
While the Q3 gross margin (23.6%) is a massive win, the sequential leap from 2.8% in Q2 shows the company is highly sensitive to product mix and yield issues. Investors should treat the current margin profile as fragile until multiple quarters of stable execution are logged.
Other KPIs
Accelerating. Net cash used in operations improved significantly from $(3.0) million in the same period last year. Combined with the $10.6 million raised in the public offering, liquidity concerns have been entirely neutralized.
Stable. Up 22% YoY. While dwarfed by the production surge, maintaining a healthy engineering revenue pipeline is critical, as it feeds future high-volume manufacturing programs.
Guidance
Accelerating. Raised from the prior range of $26 - $28 million. Represents 52% to 62% YoY growth. However, as noted, achieving the midpoint requires ~$7.25M in Q4, which would be a sequential step-down from Q3.
Reversing. Raised from prior guidance of $(2.5) - $(3.0) million. Despite achieving a positive $0.3M in Q3, the full-year guidance confirms the company will exit the year booking an operational loss for the fourth quarter.
Key Questions
Q4 Sequential Step-Down
Given the raised revenue guidance implies roughly $7.25 million for Q4—a sequential decline from Q3's $8.7 million—is this driven by customer inventory digestion, order timing, or capacity constraints?
Margin Sustainability
Gross margin swung wildly from 2.8% in Q2 to 23.6% in Q3. What structural changes were implemented by the new manufacturing leadership, and what is a normalized gross margin expectation moving forward?
Customer Concentration Risks
With two customers representing 66% of quarterly revenue, how robust is the sales pipeline in replacing this revenue if either program experiences a slowdown?